PDZK1IP1 and non-small cell lung carcinoma: As MAP17 overexpression was observed in NSCLC samples, we decided to assess whether its expression correlates with clinical characteristics in different public transcriptomic datasets (Lung Metabase (six validated cohorts), n = 1053, (SurvExpress compilation) and Directors Challenge Consortium NCI lung, n = 453, PMID: 18641660).